Zantac Intestinal Cancer

Do you suffer from intestinal cancer? Did you take Zantac? Zantac may be contaminated with NDMA and there may be significant Zantac intestinal cancer risk. In this post, we’ll take a look at the question, “Does Zantac cause intestinal cancer?”

Background: NMDA Contamination in Zantac

In late 2019, independent labs began to warn that Zantac may be contaminated with NDMA. NDMA is a cancer-causing chemical that is actually used to create cancer in laboratory rats. In April 2020, the FDA confirmed that there are “elevated” levels of NDMA in Zantac and that Zantac may cause cancer — potentially including intestinal cancer.

Does Zantac cause intestinal cancer?

Because it is ingested and digested by the body, NDMA in Zantac may cause digestive tract and gastrointestinal cancers, including stomach cancer and intestinal cancer. Roughly 20 different types of cancer may be connected to Zantac.

Recent research suggests that NDMA-contaminated Zantac intestinal cancer risk may be high.

While researchers are working to determine specific cancers that may be linked to Zantac, the evidence suggests that NDMA-contaminated Zantac may cause intestinal cancer.

There are multiple types of intestinal cancer, including colorectal cancer, small intestine cancer (including adenocarcinomas and sarcoma), carcinoid tumors, and lymphomas.

In a 1999 study, researchers determined that “A significant positive association was observed between intake of NDMA and subsequent occurrence of colorectal cancer.” Colorectal cancer is a type of intestinal cancer.

In a 2018 study examining NDMA cancer risk in another potentially dangerous drug, valsartan, researchers also found disturbing connections between NDMA and intestinal cancer. The study authors noted that “Increases in risk were observed for colorectal cancer,” a common type of intestinal cancer.

Similarly, a separate study funded by the Swedish Cancer Foundation found “an increased risk of colorectal cancer [a type of intestinal cancer] among individuals with a high intake of NDMA.”

It is important to note that a statistically significant, direct causal relationship has not been determined between contaminated Zantac and intestinal cancer, however available evidence supports a strong link.

Researchers at the Sloan Memorial Cancer Center are currently looking into potential connections between NDMA in Zantac and various forms of cancer.

Have you been diagnosed with intestinal cancer (or another type of cancer) after taking Zantac?

FEBRUARY 2023 UPDATE: Due to recent developments in the litigation, our firm is no longer accepting Zantac claims. Please stay tuned to our website for the latest information and updates.

PLEASE NOTE: At this time, the federal MDL has limited the Zantac claims we can accept to bladder, esophageal, stomach, liver, and pancreatic cancers only. We understand that other cancers may be linked, but we are unfortunately unable to assist with these claims at this time due to evidence and recent court rulings.

Those who have taken brand-name Zantac and diagnosed with intestinal cancer may be entitled to a Zantac cancer claim.

You or a loved one may be entitled to significant financial compensation and we would love to help you seek the justice and compensation you deserve.

For a FREE consultation with a Zantac lawsuit lawyer, please call 1-800-525-7111 or complete the fast and easy form below.

There is no obligation and there are no attorney fees unless we win your case and you receive financial compensation.

“I would recommend them to anyone. They fought hard for me.”

-Christine W., Riddle & Brantley client

Zantac may be associated with at least 20 different types of cancer, including:

• Intestinal cancer (including small intestine and colorectal)
• Stomach cancer
• Kidney cancer
• Liver cancer
• Pancreatic cancer
• Esophageal cancer
• Throat/nasal cancer
• Lung cancer
• Breast cancer
• Ovarian cancer
• Uterine cancer
• Testicular cancer
• Prostate cancer
• Thyroid cancer
• Brain cancer
• Bladder cancer
• Leukemia
• Non-Hodgkins lymphoma
• Multiple myeloma

For a FREE, no-obligation case review with an experienced Zantac cancer attorney, please call 1-800-525-7111. We will evaluate your claim, advise you on your best legal options, and if you decide to hire us, we will fight tirelessly for your right to compensation.

FEBRUARY 2023 UPDATE: Due to recent developments in the litigation, our firm is no longer accepting Zantac claims. Please stay tuned to our website for the latest information and updates.

IMPORTANT: A federal judge recently ruled against lawsuits concerning generic Zantac. At this point, we can only accept cases concerning use of brand-name Zantac OR “mixed” use of brand-name Zantac and generic equivalents.

Riddle & Brantley managing partner Gene Riddle and our other attorneys have been fighting for justice for the injured since 1985. In that time we’ve won many multi-million dollar settlements for our clients, and we are committed to holding drug companies accountable (see disclaimer below).

Attorney Riddle is recognized for his service to injured clients. He is a member of the Million Dollar Advocates Forum, Multi-Million Dollar Advocates Forum, and Super Lawyers. He has a prestigious AV Preeminent rating from Martindale-Hubbell and in 2014 received the Litigator Award. He has been recognized as part of The National Trial Lawyers Top 100 (see disclaimer below).

If you’ve been diagnosed with intestinal (including colorectal or small intestine) or another type of cancer after taking Zantac or ranitidine, you may be entitled to compensation. 

We would love to help you fight for justice if we can.

For a FREE, no-obligation consultation with a Zantac lawyer evaluating claims, please call 1-800-525-7111 today.

Remember, there are no upfront costs or attorney fees unless we win your case and you receive financial compensation.

Justice Counts for those diagnosed with cancer potentially as a result of taking Zantac and we would love to help you and your loved ones if we can.

***Disclaimer: No settlement agreement has been reached in any litigation regarding ranitidine (ZANTAC®), including in the Multidistrict Litigation in the United States District Court for the Southern District of Florida (case no. 20-MD-2924).

*** Disclaimer: The results mentioned are intended to illustrate the type of cases handled by the firm. These results do not guarantee a similar outcome, and they should not be construed to constitute a promise or guarantee of a particular result in any particular case. Every case is different, and the outcome of any case depends upon a variety of factors unique to that case.

*** Disclaimer: An attorney must meet certain requirements to join these organizations or receive these awards. For more information on Membership Criteria for Million Dollar Advocates Forum, Multi-Million Dollar Advocates Forum, Super Lawyers, The National Trial Lawyers Top 100, AV Preeminent by Martindale-Hubbell, and the Litigator Award, please visit our Membership Criteria page. These awards and memberships should not be construed as a promise or guarantee of a similar result. Each case is different and must be evaluated separately.